Teladoc (TDOC) Increases Despite Market Slip: Here's What You Need to Know
In the latest trading session, Teladoc (TDOC) closed at $7.87, marking a +2.61% move from the previous day.
Zacks·2d ago
More News
Hims & Hers Expands AI and Technology Focus to Advance Digital Care
HIMS boosts AI investment and appoints a new CTO as it advances personalized, technology-driven digital healthcare at scale.
Zacks·2d ago
Hims & Hers Surges 64.1% in 6 Months: How to Play the Stock?
HIMS accelerates with new men's health launches, global expansion plans and strong subscriber-driven growth, but rising costs strain gross margins.
Zacks·6d ago
Teladoc (TDOC) Stock Drops Despite Market Gains: Important Facts to Note
In the closing of the recent trading day, Teladoc (TDOC) stood at $7.49, denoting a -3.97% move from the preceding trading day.
Zacks·8d ago
Why Is Teladoc (TDOC) Up 4.6% Since Last Earnings Report?
Teladoc (TDOC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks·21d ago
Hims & Hers Scales Growth Through Subscriptions and Care Expansion
HIMS fuels growth through subscriptions, expanding care offerings and building proprietary health infrastructure at scale.
Zacks·22d ago
Hims & Hers Stock Plunges 21.3% in 3 Months: Time to Hold or Exit?
HIMS records subscriber surge and revenue growth in second-quarter 2025, but rising costs strain gross margins.
Zacks·1mo ago
Hims & Hers Drives the Consumer-Centric Transformation in Digital Care
HIMS leverages its consumer-first telehealth model, AI-driven personalization and global expansion plans to outpace industry growth.
Zacks·1mo ago
Teladoc Health Q2 Loss Narrower Than Expected on Declining Expenses
TDOC posts narrower Q2 loss and trims costs, but shares dip as U.S. revenues and visit volumes decline.
Zacks·2mo ago
Teladoc (TDOC) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Teladoc (TDOC) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.